| Name | Title | Contact Details |
|---|---|---|
Chris Patteson |
Vice President Solutions Sales East | Profile |
Roy Sorek |
Marlborough Site Head of Supply Chain Operations | Profile |
Mara Strandlund |
Chief People Officer | Profile |
Aleli Scerba |
Head of Executive Talent Acquisition | Profile |
John Botros |
Chief Financial Officer | Profile |
Genprex (Nasdaq: GNPX) is a clinical-stage gene therapy company focused on developing life-changing technologies for patients with cancer and diabetes. Genprex`s technologies are designed to administer disease-fighting genes to provide new treatment options for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches for patients with cancer and other serious diseases.
We are a clinical stage development and licensing biotechnology company focused on leveraging our Pfenex Expression Technology™ platform to develop and improve protein therapies for unmet patient needs.
Vesigen is developing groundbreaking therapeutic products directed to intracellular targets using a scalable and extracellular vesicle delivery technology.
Accuri Cytometers is a Ann Arbor, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Mapp Biopharmaceutical Inc is a Biotechnology company located in 6160 Lusk Blvd Ste C105, San Diego, California, United States.